Eran Ovadya
Director of Finance/CFO at NUREXONE BIOLOGIC INC.
Net worth: 198 475 $ as of 2024-04-29
Eran Ovadya active positions
Companies | Position | Start | End |
---|---|---|---|
NUREXONE BIOLOGIC INC. | Director of Finance/CFO | 2022-06-14 | - |
Career history of Eran Ovadya
Former positions of Eran Ovadya
Companies | Position | Start | End |
---|---|---|---|
VVT Medical Ltd. | Director of Finance/CFO | - | - |
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director of Finance/CFO | - | - |
Statistics
International
Israel | 3 |
Canada | 2 |
Operational
Director of Finance/CFO | 3 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NUREXONE BIOLOGIC INC. | Health Technology |
Private companies | 2 |
---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
VVT Medical Ltd. |
- Stock Market
- Insiders
- Eran Ovadya
- Experience